Article information

Korean J Otorhinolaryngol-Head Neck Surg. 2022;65(2):101-106

Publication date (electronic) : 2021 August 20

doi : https://doi.org/10.3342/kjorl-hns.2021.00073

Hyun Jung Kim¹, Hee Jun Yi¹, Jin-A Park¹, Nayeon Choi^,2

¹Department of Otorhinolaryngology-Head and Neck Surgery, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea

²Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

김현정¹, 이희준¹, 박진아¹, 최나연^,2

¹제주대학교 의과대학 제주대학교병원 이비인후과학교실

²성균관대학교 의과대학 삼성서울병원 이비인후과학교실

Address for correspondence Nayeon Choi, MD Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel +82-2-3410-3579 Fax +82-2-3410-6987 E-mail chlskduschoi@naver.com

Received 2021 February 2; Revised 2021 March 12; Accepted 2021 March 21.

Trans Abstract

Introduction

The ranula is a retention cyst made of extravasated saliva from a damaged salivary duct or gland [1,2]. Ranula could be presented as intraoral or submandibular mass. An intraoral ranula is confined to the floor of the mouth and a plunging ranula is herniated cyst located below the mylohyoid muscle and present as a lump in the upper part of the neck [3].

Various treatment methods have been practiced based on different concepts of pathogenesis. Simple excision of ranula, cyst extirpation, excision of the sublingual gland, and sclerotherapy of ranula sac have been popular procedures for treatment of ranula [4,5]. Pathological studies reported that most ranulas are pseudocysts without epithelial lining arisen from sublingual gland [4,6]. Therefore, simple excision and extirpation of ranula have been avoided which targeted only ranula sac, not sublingual gland. Excision of the sublingual gland is recently considered to be a reasonable treatment [7,8]. However, excision of sublingual gland demonstrated several disadvantages such as insufficient removal of sublingual gland, necessity of general anesthesia and the risk of damage to the adjacent structures including the submandibular gland duct and lingual nerve [9]. Therefore, nonsurgical therapies with less associated morbidity have been required for the treatment of ranula. Sclerosing agents including OK-432 (picibanil), bleomycin, and ethanol have been introduced to be highly effective and minimal invasive in the treatment of ranula [2,10-12]. They evoke inflammatory reaction and increased endothelial permeability that lead to shrinkage of the cystic space.

There has been no consensus about the definitive management of plunging ranula because of a lot of variation between previous studies. Previous studies enrolled the subjects with heterogenous types of ranula and they did not focus on plunging ranula or intraoral ranula which could affect to treatment methods and outcomes [13-15]. Furthermore, they had practiced inconsistent procedures such as sublingual gland excision, ranula excision or extirpation. In addition, they did not report about clinical course and salvage treatment after failure of initial treatment. Therefore, the aim of study was to evaluate the treatment outcomes of sublingual gland excision and ethanol sclerotherapy for plunging ranula and investigated the salvage treatment and outcomes of recurred ranula after initial treatment.

Subjects and Methods

Patients

This study was approved by Institutional Review Board (2020-09-016) of authors’ hospital. Total 223 patients had visited our clinic for the management of sublingual gland ranula from 2002 to 2019. Patients who had intraoral ranula (n=119), repeated aspiration of ranula (n=17), and observation without treatment (n=13) were excluded (Fig. 1). Finally, 74 patients were analyzed who received excision of sublingual gland (excision group, n=35) and sclerotherapy of ranula (sclerotherapy group, n=39). All patients had been observed more than 3 months after initial procedure and we performed additional procedures for patients who revealed recurrent plunging ranula. Recurrent patients were also observed until 3 months after salvage surgery and treatment outcomes were investigated at the last follow-up.

Fig. 1.

The patient with sublingual gland ranula (n=223) and enrollment and clinical courses of patients with plunging ranula treated with excision of sublingual gland (n=35) and ethanol sclerotherapy (n=39).

Results

Baseline characteristics of the enrolled patients

Mean age was 28.8±13.1 years in the excision group and 28.3±11.3 years in the sclerotherapy group, and it did not show statistical difference (p=0.737). The excision group consisted of 26 males and 9 females and the sclerotherapy group consisted of 25 males and 14 females. Distribution of sex was not significantly different (p=0.452) between the two groups (Table 1). In the sclerotherapy group, there was no complications like skin necrosis or infection, and pain was tolerable with oral acetaminophen in all patients.

Table 1.

Baseline characteristics and treatment outcomes of the sublingual gland excision group and the ranula sclerotherapy group (n=74)

Discussion

We investigated the outcomes of excision of sublingual gland and ethanol sclerotherapy for plunging ranula as an initial and salvage treatment. Sublingual gland excision (recurrence rate of 8.6%) was identified as more effective treatment than sclerotherapy (recurrence rate of 51.3%), and two treatment methods might have complementary effect in recurred cases in our study.

Plunging ranula has unique clinical presentations in comparison with other types of ranula, which may appear as a submandibular mass without visible intraoral involvement [3]. In addition, plunging ranula and intraoral ranula showed different clinical courses and they required different approach for diagnosis and treatment [6,8,13,15]. However, many previous studies did not classify the subtype of ranula [13,15-17]. Therefore, it has been necessary to perform a large-scaled study confined to plunging ranula, and we focused on patients with plunging ranula to have homogeneous enrollment of subjects and obtain reliable results.

In addition, many previous studies have performed quite variable treatment methods including needle aspiration, surgical excision of the cyst, sublingual gland excision, marsupialization, and sclerotherapy [4,5,18,19]. Parekh, et al. [7] reported the outcomes of 139 plunging ranula that 70% of incision and drainage, 53% of marsupialization, 85% of excision of the cyst, 3.8% of cyst and sublingual gland excision together, and 0% of intraoral excision of the sublingual gland with drainage of cyst showed recurrence. Sigismund, et al. [20] reported that 13.6% of marsupialization, 3.6% of complete sublingual gland excision, and 36.4% of ranula excision alone were recurred after treatment. Crysdale, et al. [21] demonstrated that the incidence of recurrence was 100% after incision and drainage of ranula, 61% after simple marsupialization, and 0% after sublingual gland excision. Yang and Hong [22] demonstrated successful treatment in all 23 patients by the sublingual gland with evacuation of cyst.

As mentioned above, different types of surgery demonstrated quite variable treatment outcomes and sublingual gland excision has been accepted as the most effective treatment method [2,6,8]. In the excision group (n=35), we have consistently performed sublingual gland excision with ranula extirpation which showed recurrence rate of 9.6% as an initial treatment. Our study demonstrated relatively high recurrence rate in the excision group in comparison with previous studies. It caused by insufficient infection control before treatment and remained sublingual gland at posterior and deep mouth floor area.

Surgical excision of sublingual gland was the first choice of treatment, but many patients were reluctant to the invasive procedure under general anesthesia. Furthermore, insufficient surgery, recurrence, and the risk of damage to the adjacent structures including the submandibular gland duct and lingual nerve have been reported when performing sublingual gland excision [9]. Therefore, nonsurgical therapies with less associated morbidity have been also required for the treatment of ranula. OK-432 (picibanil), a sclerosing agent, has been widely used in previous studies which is highly effective and to have minimal side effects for the treatment of cystic lymphangioma and plunging ranula [2,10,23]. The mechanism of sclerotic agent is that it immediately evokes the infiltration of the inflammatory cells into the cystic spaces and extensive production of cytokines, including interleukin-6 and tumor-necrotic factor [24].

Fukase, et al. [24] reports 100% resolution of 11 cases of plunging ranula after multiple injections, but the success rate after the first injection was only 45.5%. Rho, et al. [14] found the success rate for treating plunging ranulas in their series was only 33.3% after one injection of OK-432. To the best of our knowledge, previous studies about sclerotherapy with OK-432 for plunging ranula were usually case series and not comparative study with other treatment methods and they did not describe the clinical course after failure of initial treatment. In addition, OK-432 has been hard to access in the South Korea and other countries including United States. In South Korea, physician should request drug before several weeks ago to Korea Orphan & Essential Drug Center.

Therefore, there has been several trials of ethanol injection for ranula [25,26], and we have also practiced ethanol sclerotherapy in this study and compared the outcomes between surgery and sclerotherapy. Previous retrospective study of 20 patients who had ethanol injection demonstrated that 9 patients (45%) demonstrated complete disappearance of the ranula and 11 (55%) showed partial response which was comparable to OK-432 sclerotherapy [26]. In our study, we performed the ethanol injection in the sclerotherapy group (n=39), and they have a recurrence rate of 51.3% as an initial treatment.

After initial treatment, 23 (31.1%) patients were recurred in the excision (n=3) and the sclerotherapy group (n=20). Interestingly, patients who recurred after initial treatment were all cured by salvage treatment different from initial treatment (n=7). Otherwise, patients who underwent same procedure with initial procedure (n=11) recurred in 8 patients (72.7%). Two treatment methods used in this study are based on different mechanism that the excision of sublingual gland is removal of the causative salivary gland and sclerotherapy targets leaked cyst with adjacent salivary gland. We assume that these two different treatment methods have complementary effect to each other in recurred patients. We found this complementary effect in 6 cases in the sclerotherapy group and only 1 case in the excision group. Therefore, we are careful to conclude because of the small number of recurred patients especially in the excision group, but two surgeries may have complementary effects to each other. After the failure of sclerotherapy, the excision of sublingual gland should be considered as a salvage treatment.

This study presented the comparison between the excision of sublingual gland and the sclerotherapy for the patients with plunging ranula and management of recurrence. We have limitations that it is difficult to perform the statistical analysis of management of recurrence because of small number of recurred cases especially in the excision group. In addition, this study was retrospective with non-randomized patient enrollment which could cause selection bias.

In conclusion, excision of sublingual gland is more effective treatment for plunging ranula than ethanol sclerotherapy as an initial treatment. In recurred cases after ethanol sclerotherapy, sublingual gland excision was also effective. We might consider the salvage treatment method other than the initial treatment to manage the recurred cases.

Article information Continued